Scientific Director

About PhaSER Biomedical

PhaSER Biomedical is an innovative biotechnology company focused on humanised in vivo models and tools for advancing the drug development paradigm and predicting drug-drug interactions in patients. We collaborate with global clients, research institutes, drug regulators such as the MHRA and philanthropic foundations such as the Bill & Melinda Gates Foundation.

PhaSER Biomedical is entering an exciting phase of growth, including a major collaboration with the Medicines and Healthcare Products Regulatory Agency (MHRA) to develop state-of-the‑art in silico approaches predicting the risk of adverse drug reactions in patients.

As Scientific Director, you will serve as a principal scientific authority within PhaSER, operating as the second‑in‑command to the CSO. You will provide strategic scientific direction, oversee in vivo and in silico research programmes, support cross‑functional integration, and ensure the quality, integrity, and impact of our scientific output. You will also lead on technical discussions with clients, assisting in winning new business and representing the company to its clients.

This position requires broad and deep scientific expertise, proven leadership, and the ability to operate at both strategic and hands‑on levels.

• Support the CSO in setting scientific strategy across in vivo, computational, and translational research programmes.
• Lead cross‑disciplinary scientific planning to integrate humanised model data, pharmacology, and computational methodologies.
• Represent PhaSER’s scientific capabilities to customers, partners, funders, and external collaborators, including attendance at key scientific conferences.

• Provide senior oversight of in vivo pharmacokinetic and pharmacodynamic studies in humanised models.
• Oversee the development and validation of computational and in silico models predicting drug‑drug interactions and toxicities.
• Ensure effective coordination across laboratory, computational, and regulatory work streams (including MHRA‑linked activities).

• Maintain scientific integrity across all PhaSER research programmes.
• Lead the review and interpretation of complex datasets.
• Support the development and maintenance of scientific SOPs and quality standards.

• Mentor scientific staff, including early‑career researchers, computational modellers, and laboratory scientists.
• Support recruitment, onboarding, and growth of the scientific organisation.
• Foster a collaborative, evidence‑driven research culture.

• Liaise with internal teams and external partners to design experimental plans and data‑generation strategies.
• Engage with stakeholders from biopharma, academia, philanthropic foundations, and regulatory agencies.
• Contribute to scientific reports, manuscripts, grant applications, and presentations.

• Extensive experience in biomedical research, pharmacology, toxicology, drug development, or related fields.
• Demonstrated leadership experience in managing scientific teams or programmes.
• Strong track record of scientific innovation and delivery in a multidisciplinary environment.
• Proven ability to engage effectively with partners across academia, industry, and regulatory bodies.
• Excellent organisational, communication, and scientific writing skills.
• Comfortable using digital tools (e.g., Microsoft 365).
• General scientific literacy across pharmacokinetics, pharmacodynamics, and computational or systems‑based methodologies.

• PhD in pharmacology, biomedical sciences, toxicology, or a closely related discipline.
• Experience with humanised models, ADME/PK, systems pharmacology, or computational modelling.
• Knowledge of the drug development paradigm and regulatory science.

Applicants must possess the right to live and work in the United Kingdom and must not require a work visa.

This position is an office‑based position in Dundee, Scotland.